Dubai: The Julphar Gulf Pharmaceutical Industries board has recommended the distribution of a 16 per cent cash dividend and 3 per cent bonus shares for the year 2016, subject to a formal approval.
“Last year witnessed economic and political challenges impacting the region. However, we managed to maintain a strong performance, which demonstrates our solid and stable foundation. We are deeply committed to enhance our shareholders’ value and we believe in our long-term vision to be the leader in enabling access to quality pharmaceutical products in Middle East and Africa,” Julphar’s chairman Shaikh Faisal Bin Saqr Al Qasimi said in a statement.
During the meeting, board members also approved the company’s financial statements for the year ended December 31, 2016.
